{"log_id": 2245920581049828929, "direction": 0, "words_result_num": 48, "words_result": [{"probability": {"variance": 0.029384, "average": 0.904648, "min": 0.368338}, "location": {"width": 895, "top": 133, "height": 35, "left": 175}, "words": "心绞痛发作的频糜和程度加重。因此,建选择性β受体阻滞剂不能用于此类惠者。选择性β受体阻"}, {"probability": {"variance": 4.6e-05, "average": 0.993255, "min": 0.976979}, "location": {"width": 205, "top": 171, "height": 28, "left": 175}, "words": "在使用时也必须慎重"}, {"probability": {"variance": 5.5e-05, "average": 0.987422, "min": 0.980003}, "location": {"width": 38, "top": 80, "height": 124, "left": 1113}, "words": "品骑"}, {"probability": {"variance": 0.0219, "average": 0.91268, "min": 0.441291}, "location": {"width": 851, "top": 197, "height": 35, "left": 221}, "words": "对支气管哮喘成其他慢性阻蒸性肺病患者,应同时给予足够的扩支气管治疗,β2受体激动剂的剂"}, {"probability": {"variance": 0.062148, "average": 0.724333, "min": 0.404221}, "location": {"width": 144, "top": 238, "height": 24, "left": 174}, "words": "撒可能需要加"}, {"probability": {"variance": 0.022976, "average": 0.92979, "min": 0.428483}, "location": {"width": 710, "top": 261, "height": 35, "left": 219}, "words": "美托洛尔的治疗对糖代谢的影响成掩盖低糖的危险低于非选择性β受体阴滞剂"}, {"probability": {"variance": 0.006432, "average": 0.968634, "min": 0.598095}, "location": {"width": 661, "top": 294, "height": 32, "left": 223}, "words": "在罕的情况下,原有的中度房室传导异常可能加重(可能导致房室阻滞)"}, {"probability": {"variance": 0.006721, "average": 0.962639, "min": 0.612155}, "location": {"width": 853, "top": 324, "height": 35, "left": 218}, "words": "β受体阻滞剂的治疗可能会妨碍对过敏反应的治疗,常规削量的肾上腺素治疗并不总能得到预期"}, {"probability": {"variance": 0.006703, "average": 0.949508, "min": 0.638906}, "location": {"width": 606, "top": 357, "height": 35, "left": 176}, "words": "的疗效。铬细胞瘤患者若使用本品,应考虑合并使用a受体阻滞剂"}, {"probability": {"variance": 0.022782, "average": 0.904182, "min": 0.467387}, "location": {"width": 854, "top": 388, "height": 33, "left": 222}, "words": "本晶应尽可能遂步撒药,整个撤约过程至少用二周时间,剂量逐渐减低,直至最后减至25mg50mg"}, {"probability": {"variance": 0.009725, "average": 0.959998, "min": 0.426301}, "location": {"width": 893, "top": 417, "height": 36, "left": 177}, "words": "片的半片)。在此期间,特别是对于已知伴有缺血性心脏病的患者应进行密切监测,在撤除β受体阻"}, {"probability": {"variance": 0.016217, "average": 0.926272, "min": 0.535856}, "location": {"width": 528, "top": 452, "height": 31, "left": 175}, "words": "期间,可能会便冠状动脉事件,包括心脏猝死的危险增加"}, {"probability": {"variance": 0.019736, "average": 0.927922, "min": 0.392843}, "location": {"width": 806, "top": 481, "height": 33, "left": 222}, "words": "在手术应告知麻醉医师患者正在服用本品、对接受手术的患者,不推荐停用β受体阻滞剂"}, {"probability": {"variance": 0.015776, "average": 0.953828, "min": 0.533331}, "location": {"width": 264, "top": 518, "height": 25, "left": 223}, "words": "对驾驶汽车和操作机械的影瑞"}, {"probability": {"variance": 0.01423, "average": 0.948427, "min": 0.408894}, "location": {"width": 848, "top": 543, "height": 34, "left": 222}, "words": "在用本品治疗过程中可能会发生眩晕和波劳,因此在需要中注意力时,如驾驶和操作机械时应"}, {"probability": {"variance": 0, "average": 0.946332, "min": 0.946332}, "location": {"width": 41, "top": 582, "height": 23, "left": 178}, "words": "慎"}, {"probability": {"variance": 0.051227, "average": 0.857419, "min": 0.411291}, "location": {"width": 103, "top": 612, "height": 24, "left": 224}, "words": "运动慎用"}, {"probability": {"variance": 0.037125, "average": 0.887207, "min": 0.486799}, "location": {"width": 235, "top": 656, "height": 26, "left": 182}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.010745, "average": 0.946225, "min": 0.484741}, "location": {"width": 851, "top": 681, "height": 35, "left": 224}, "words": "妊娠期使用β受体阻滞剂可引起胎儿各种问题,包括胎儿发育迟缓。β-受体阻滞剂对胎儿和新生"}, {"probability": {"variance": 0.011249, "average": 0.95228, "min": 0.469929}, "location": {"width": 625, "top": 714, "height": 33, "left": 179}, "words": "儿可产生不利影响,尤其是心动过缓,因此在妊娠或分娩期间不宜使用"}, {"probability": {"variance": 0.007351, "average": 0.964974, "min": 0.66877}, "location": {"width": 351, "top": 764, "height": 27, "left": 183}, "words": "【儿童用药】儿童使用本品的经验有限"}, {"probability": {"variance": 0.000662, "average": 0.989117, "min": 0.882871}, "location": {"width": 794, "top": 806, "height": 34, "left": 183}, "words": "【老年用药】老年人的药代动力学与年轻人相比无明显改变,因而老年患者用量无需调整"}, {"probability": {"variance": 0.001098, "average": 0.976877, "min": 0.900377}, "location": {"width": 150, "top": 860, "height": 25, "left": 185}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.010892, "average": 0.968708, "min": 0.431632}, "location": {"width": 851, "top": 883, "height": 35, "left": 227}, "words": "美托洛尔是种CYP2D6的作用底物抑制CYP2D6的药物可影响美托洛尔的血浆浓度。抑制"}, {"probability": {"variance": 0.024963, "average": 0.908974, "min": 0.444244}, "location": {"width": 886, "top": 915, "height": 33, "left": 180}, "words": "CYP2D6的药物尼丁、特比萘芬、美罗西汀、氟西汀、舍曲林、塞来普布、普帕和苯海拉明"}, {"probability": {"variance": 0.009017, "average": 0.965845, "min": 0.544838}, "location": {"width": 567, "top": 948, "height": 30, "left": 180}, "words": "对服用本品的患者,在上述药物的治疗开始应减低本品的剂量"}, {"probability": {"variance": 0.0164, "average": 0.950188, "min": 0.482564}, "location": {"width": 290, "top": 989, "height": 30, "left": 227}, "words": "本品应避免与下列药物会并使用:"}, {"probability": {"variance": 0.015696, "average": 0.946635, "min": 0.418993}, "location": {"width": 843, "top": 1017, "height": 34, "left": 228}, "words": "巴比妥类物:巴比类药物(对戊巴比作过研究)可通过酶诱导作用使美托洛尔的代谢增加"}, {"probability": {"variance": 0.007802, "average": 0.971185, "min": 0.534738}, "location": {"width": 840, "top": 1049, "height": 34, "left": 228}, "words": "普罗帕酮:4例已经使用美托洛尔的患者,在给予普罗帕酮后,美托洛尔的血浆浓度增高2~5倍"}, {"probability": {"variance": 0.011495, "average": 0.956231, "min": 0.371614}, "location": {"width": 900, "top": 1081, "height": 33, "left": 181}, "words": "其中2例发生与美洛尔育关的副作用。这种相互作用在8例健康志愿者中得到证实对于这种互作"}, {"probability": {"variance": 0.010551, "average": 0.951145, "min": 0.419478}, "location": {"width": 900, "top": 1112, "height": 32, "left": 182}, "words": "用的可能的解释是:普罗帕酮与奎尼丁相似,可通过细胞色素P45026途径抑制美托洛尔的代谢。由"}, {"probability": {"variance": 0.022133, "average": 0.920426, "min": 0.423621}, "location": {"width": 625, "top": 1143, "height": 33, "left": 185}, "words": "于罗舶酮也具有β受体阻滞效应,其与美托涤尔的联合使用很难掌握"}, {"probability": {"variance": 0.030723, "average": 0.882286, "min": 0.385499}, "location": {"width": 848, "top": 1183, "height": 31, "left": 229}, "words": "维拉帕:维拉米与β受体阻滞剂会用时(已有与网替洛尔、普洛尔和噪浴尔合用的报道"}, {"probability": {"variance": 0.013093, "average": 0.950027, "min": 0.47681}, "location": {"width": 899, "top": 1213, "height": 33, "left": 181}, "words": "有可能引起心动过缓和血压下降维拉米和β受体阻灌剂对于房室传导和窦房结功能有相加的抑制作"}, {"probability": {"variance": 0, "average": 0.821831, "min": 0.821831}, "location": {"width": 23, "top": 1253, "height": 22, "left": 183}, "words": "用"}, {"probability": {"variance": 0.012406, "average": 0.94925, "min": 0.60725}, "location": {"width": 410, "top": 1289, "height": 27, "left": 230}, "words": "本与下药物盒并使用时可能需要调整剂量"}, {"probability": {"variance": 0.002324, "average": 0.70626, "min": 0.660953}, "location": {"width": 62, "top": 1322, "height": 23, "left": 231}, "words": "胺桃司"}, {"probability": {"variance": 0.023922, "average": 0.908872, "min": 0.450501}, "location": {"width": 627, "top": 1316, "height": 31, "left": 336}, "words": "例报道量示,同时使用胺碘和美托洛尔,有可能发生明显的突性心动"}, {"probability": {"variance": 0.012525, "average": 0.941713, "min": 0.508727}, "location": {"width": 898, "top": 1347, "height": 29, "left": 186}, "words": "的半衰期很长(约50天),这意珠着在胺碘酮治疗停止后较长的一段时间内,使用美格尔仍有可能发"}, {"probability": {"variance": 0.051892, "average": 0.780865, "min": 0.43844}, "location": {"width": 165, "top": 1383, "height": 24, "left": 184}, "words": "两约的工作用"}, {"probability": {"variance": 0.026818, "average": 0.903908, "min": 0.357056}, "location": {"width": 853, "top": 1401, "height": 42, "left": 233}, "words": "I类抗心率失常药物:类抗心率常药物与β受体阻滞剂有加的负性肌作期故在心室"}, {"probability": {"variance": 0.02779, "average": 0.906272, "min": 0.378928}, "location": {"width": 930, "top": 1426, "height": 47, "left": 184}, "words": "功能受损的患者中,有可能引起严重的血流动力学副作用。病态窦房结综合征和病理性房室传爵滞的人"}, {"probability": {"variance": 0.024086, "average": 0.920546, "min": 0.358905}, "location": {"width": 906, "top": 1470, "height": 29, "left": 187}, "words": "患者,也应避免同时使用美托涤尔和丨类抗心率失常药物丙胺和关托洛尔之间的作用已有明确"}, {"probability": {"variance": 0.000148, "average": 0.987011, "min": 0.974612}, "location": {"width": 104, "top": 1507, "height": 22, "left": 187}, "words": "的资料明"}, {"probability": {"variance": 0.060706, "average": 0.762065, "min": 0.352088}, "location": {"width": 208, "top": 1536, "height": 24, "left": 236}, "words": "丰体类镇炎抗风"}, {"probability": {"variance": 7.6e-05, "average": 0.96755, "min": 0.958827}, "location": {"width": 81, "top": 1534, "height": 23, "left": 553}, "words": "发N"}, {"probability": {"variance": 0.018577, "average": 0.89102, "min": 0.618746}, "location": {"width": 362, "top": 1529, "height": 31, "left": 684}, "words": "抗炎镇痛抵消β受体阻浩剂的离"}, {"probability": {"variance": 5.9e-05, "average": 0.982996, "min": 0.971262}, "location": {"width": 102, "top": 1601, "height": 47, "left": 1071}, "words": "仅供存档"}], "language": 3}